Bukmedis, UAB - company info and details

Company age: 7 y. 0 mo.

Update

Company overview

Company name Bukmedis, UAB
Company code 305280534
VAT code LT100012742412
Registered address Kėdainių r. sav., Krakės, Vilniaus g. 17, LT-58249
Registration date 2019-10-09 Company age: 7 y.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 98,514 € -6% History
Profit (2025) 21,013 € -44% History
Share capital 2,500 €
Number of employees 3 History
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity Manufacture of furniture
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Bukmedis, UAB (company code 305280534) is an operational private limited liability company registered on 9 October 2019. It is a privately owned Lithuanian company, with governance described as CEO only, and it is classified as a micro company in the national private non-financial companies sector. Its main activity is Manufacture of furniture (EVRK C.31.00.00). The company is based in Krakes, Kedainiu district municipality, Kaunas County, at Vilniaus g. 17, LT-58249. Registered share capital is EUR 2.5K.

Financially, Bukmedis generated EUR 98.5K in revenue in 2025, compared with EUR 104.4K in 2024 and EUR 43.0K in 2023. Net profit was EUR 21.0K in 2025, after EUR 37.5K in 2024 and EUR 5.9K in 2023. Profit margin stood at 21.3% in 2025, down from 35.9% in 2024 but above 13.8% in 2023. Equity increased to EUR 80.2K in 2025, while liabilities remained low at EUR 4.0K, leaving an equity ratio of 95.3%.

The company averaged 2 employees in 2023, 2024 and 2025, and 3 employees so far in 2026.

Download a detailed company report

Make confident decisions with all the information about Bukmedis, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report